Steve Rusckowski is Chairman, Chief Executive Officer and President of Quest Diagnostics.
Since joining Quest Diagnostics as President and Chief Executive Officer in May 2012, Mr. Rusckowski has focused on transforming the company, based on its compelling vision of “Empowering better health with diagnostic insights.” Under his leadership, the company has refocused on its core diagnostic information services business, sold non-core assets, delivered disciplined deployment, including share repurchases and acquisitions, and simplified its organizational structure to better serve customers by removing complexity, speeding decision making and empowering employees. He was elected Chairman of the Board in December 2016.
Prior to joining Quest Diagnostics, Mr. Rusckowski was CEO of Philips Healthcare, which became the largest unit of Royal Philips Electronics under his leadership. He joined Philips in 2001 when it acquired the Healthcare Solutions Group he was leading at Hewlett-Packard/Agilent Technologies.
Mr. Rusckowski is a member of the Board of Directors of the American Clinical Laboratory Association, and served as its Chairman from 2014 to 2017. He is also an Emeritus Director of Project Hope, a global health education and humanitarian assistance organization.
Mr. Rusckowski earned a Master of Science degree in Management from the Massachusetts Institute of Technology’s Sloan School of Management and a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute.
What is Stephen H. Rusckowski's net worth?
The estimated net worth of Stephen H. Rusckowski is at least $54.04 million as of May 24th, 2022. Mr. Rusckowski owns 334,833 shares of Quest Diagnostics stock worth more than $54,035,350 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Rusckowski may own. Learn More about Stephen H. Rusckowski's net worth.
How do I contact Stephen H. Rusckowski?
Has Stephen H. Rusckowski been buying or selling shares of Quest Diagnostics?
Stephen H. Rusckowski has not been actively trading shares of Quest Diagnostics during the last quarter. Most recently, Stephen H. Rusckowski sold 282,408 shares of the business's stock in a transaction on Tuesday, May 24th. The shares were sold at an average price of $140.12, for a transaction totalling $39,571,008.96. Following the completion of the sale, the chief executive officer now directly owns 334,833 shares of the company's stock, valued at $46,916,799.96. Learn More on Stephen H. Rusckowski's trading history.
Who are Quest Diagnostics' active insiders?
Quest Diagnostics' insider roster includes Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.
Are insiders buying or selling shares of Quest Diagnostics?
In the last twelve months, insiders at the medical research company sold shares 10 times. They sold a total of 39,850 shares worth more than $5,692,423.40. The most recent insider tranaction occured on November, 6th when CAO Michael J Deppe sold 18,755 shares worth more than $2,889,207.75. Insiders at Quest Diagnostics own 0.8% of the company.
Learn More about insider trades at Quest Diagnostics. Information on this page was last updated on 11/6/2024.
